SHATTUCK LABS, INC.

Transcripts Shattuck Labs, Inc.

Equities

STTK

US82024L1035

Market Closed - Nasdaq Other stock markets 04:00:01 2024-05-31 pm EDT			5-day change	1st Jan Change
7.39 ^USD	-0.27%		-1.34%	+3.65%

May. 14	Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of Sl-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (Hr-Mds) and Tp53 Mutant Acute Myeloid Leukemia Patients At the European Hematology Association 2024 Congress	CI
May. 02	Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Shattuck Labs, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 12:00 PM	Jan. 11
Transcript : Shattuck Labs, Inc. - Special Call	Dec. 13
Transcript : Shattuck Labs, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Transcript : Shattuck Labs, Inc., Q4 2022 Earnings Call, Feb 23, 2023	23-02-23
Transcript : Shattuck Labs, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-12-2023 11:15 AM	23-01-12
Transcript : Shattuck Labs, Inc., Q3 2022 Earnings Call, Nov 08, 2022	22-11-08
Transcript : Shattuck Labs, Inc. Presents at Citi's 17th Annual BioPharma Conference, Sep-08-2022 02:40 PM	22-09-08
Transcript : Shattuck Labs, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 11:15 AM	22-01-13
Transcript : Shattuck Labs, Inc. - Special Call	21-11-12
Transcript : Shattuck Labs, Inc., Q2 2021 Earnings Call, Aug 12, 2021	21-08-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer